A multitude of guanine nucleotide exchange factors (GEFs) regulate Rapl small
In vivo functions of Rap 1 GEFs have been analyzed by gene targeting. Mice lacking C3G
show embryonic lethality shortly after implantation [8] . In contrast, mice lacking CaIDAG-GEFI are viable, but their platelets are severely compromised in integrin-dependent aggregation [9] . Recently, we have generated RA-GEF-2 knockout mice, in which tumor necrosis factor-a-dependent integrin activation and adhesion were impaired specifically in splenic B cells [10] . However, no mouse model that exhibits embryonic vascular abnormalities due to deficient Rap 1 signaling has been reported.
In this study, we have generated mice with functional disruption of the RA -GEF-J allele and found that RA-GEF-r l -mice show mid-gestation embryonic lethality, which is closely associated with severe defects in embryonic vasculogenesis. (5' -GCGTGTGTTGGAGGTTATCCCAG-3 '), and p3
Materials and methods

Construction of the targeting vector. An RA-GEF-J
(5'-CGAGTCCTGAACATAAGGGCAGGG-3') ( Fig. lA) . PCR genotyping of embryos later than E8.5 was done by using DNA isolated from their extraembryonic membranes.
Western blot analysis. Western blot analysis was performed as described [12, 13] with affinity-purified rabbit anti-RA-GEF -1 antibody raised against a synthetic peptide of the C-terminal 21 residues of mouse RA-GEF-l (CDADPRLAPFQPQGFAGAE ED) (Operon Biotechnologies, Tokyo, Japan). Anti-mouse a-actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was used as a loading control.
Reverse transcription (RT)-PCR.
The total cellular RNA was prepared from whole embryos, and RT-PCR was done as described previously [13] . The following primers were used for amplification of the RA-GEF-l mRNA:
and Histological analysis. Embryos were embedded in paraffin, sectioned (4-/-lm), and stained with hematoxylin and eosin (HE). Whole-mount immunostaining of embryos and yolk sacs was performed as described previously [14] using anti-mouse platelet endothelial cell adhesion molecule-l (PECAM-l) antibody (BD Biosciences-pharmigen. San Diego, CA) and horseradish peroxidase-conjugated sheep anti-rat immunoglobulin G (IgG) antibody (GE Healthcare Bio-Sciences, Piscataway, NJ). For immunofluorescence staining, yolk sacs were embedded in OCT compound (Tissue-Tek, Miles, Elkhart, IN), sectioned, and stained with primary antibody against RA-GEF-l or PECAM-l, followed by Alexa Fluor 488-labeled anti-rabbit IgG (Molecular Probes, A-II034) or Alexa Fluor 546-labeled anti-rat IgG (Molecular Probes, A-ll081) antibodies. Fluorescence was detected by confocal laser scanning microscopy (LSM510 META; Carl Zeiss, Jena, Germany).
Results
Generation of the RA-GEF-J null allele
The RA_GEF_Jf1 Ox allele was created in mouse 129/0Ia-derived ES cells by homologous recombination (Fig. IA) . One out of 9S G418-resistant ES cell clones was verified to carry the RA_GEF_Jfl ox allele (Fig. IB) . This ES clone was used to derive RA_GEF_Jfl oxl + mice, whose genotypes were verified by Southern blot hybridization and peR (Fig. I e) .
Subsequently, the RA-GEF-r allele was generated through ere-mediated deletion of exonIS-loxP-TK-neo (Fig. Ie) . Embryo genotypes were determined by peR using allele-specific primers as exemplified in Fig. ID .
Embryonic lethality of RA -GEF-r l -mice
No newborn RA-GEF-r l -pups were present after examining 174 pups from the cross-breeding of RA-GEF-J+I-mice, indicating that RA-GEF-I deficiency results in embryonic lethality (Table I) . RA-GEF-J+I-mice were born at a normal Mendelian ratio and appeared healthy and fertile (Table I and data not shown). RA-GEF-rl-embryos appeared normal until E7.S with normal development of the three embryonic germ layers and amnion (data not shown). At E8.S, RA-GEF-r l -embryos were observed at the expected Mendelian ratio (Table I ). However, they exhibited variable appearances ranging from apparently normal ( Fig. 2A, middle panel) to noticeably reduced in size with no embryonic turning ( Fig.   2A , right panel). At E9.S, RA-GEF-rl-embryos appeared grossly abnormal with reduced sizes and undulated neural tubes without closure of the anterior and posterior pores. They were arrested in development after forming IS somites without completion of embryonic turning ( Fig. 2B) . Furthermore, E9.5 RA-GEF-r l -embryos had pale yolk sacs lacking obvious blood vessels, whereas yolk sacs of all E9.S wild-type embryos exhibited large vitelline blood vessels filled with blood, suggesting a gross abnormality in blood vessel formation in RA-GEF-r l -embryos ( Fig. 2e) . At ElO.S-12.S, they were deteriorated and completely absorbed at around E13.S (Table I) .
Expression of RA-GEF-J in mouse embryos
Western blot analysis confirmed the expression of RA-GEF-l in ElO.S wild-type embryos as a major 160 kDa band, which was not observed in RA-GEF-r l -embryos ( Fig.   20 ). The expression of RA-GEF-I was undetectable until E7.S but exhibited a marked S increase at E8.5, when abnormal vascular development seems to start in RA-GEF-r l -mice (Fig. 2E ). The spatial expression pattern of RA-GEF-l in E8.5 yolk sacs was examined by immunofluorescence staining (Fig. 2F ). RA-GEF-l was widely expressed with strong expression at vascular endothelial cells positive for PECAM-l.
Defective vascular development in RA-GEF-r l -embryos
We visualized the vascular network of E9.5 RA-GEF-r l -and wild-type embryos by whole-mount immunostaining with anti-PECAM-l antibody. At E9.5, wild-type embryos showed well-organized blood vessels such as dorsal aortae, aortic arches, cranial vessels and intersomitic vessels (Fig. 3A, left panel) . In contrast, RA-GEF-rl-embryos showed varying vascular morphology. Most of them lacked major blood vessels but possessed delicate plexus-like structures at the site of dorsal aortae, suggesting a severe defect in vasculogenesis (Fig. 3A, middle panel) . Three out of 12 embryos examined had an abnormal balloon-shaped allantois strongly positive for PECAM-l (Fig. 3A, right panel) . The vasculature of these embryos was less severely affected, and structures like dorsal aortae and intersomitic vessels were visible albeit hypomorphic. The balloon-shaped allantois phenotype showed remarkable similarity to that of mice deficient in 0.4 integrin [15] or VCAM-l [16] .
Defective vascular development in RA-GEF-r l -yolk sacs
The yolk sac vasculature is initiated with the development of blood islands derived from distinct mesodermal cells around E8.0 [17] . The blood islands fuse with each other and form lumina, eventually leading to formation ofa primitive vascular plexus by E8.75. Subsequently, large vitelline vessels and a meshwork of smaller vessels arise from the existing capillary plexus around E9.5 by angiogenic vascular remodeling. We visualized the vascular network in yolk sacs with PECAM-l immunostaining. E9.5 wild-type yolk sacs showed formation of large vitelline collecting vessels and a network of smaller vessels (Fig. 3B) . In striking contrast, in RA-GEF-r l -yolk sacs, blood islands surrounded by PECAM-l-positive vascular endothelium were visible, but they failed to coalesce to form a honeycomb-like primitive vascular plexus, indicating a failure in vasculogenesis (Fig. 3B) .
We next analyzed sections of yolk sacs by HE staining. At E8.5, blood islands formed in RA-GEF-r l -yolk sacs were indistinguishable from those in wild-type, in which fetal nucleated erythrocytes were surrounded by an endothelial layer forming close contacts between visceral endodermal and mesodermal layers, indicating that hematopoiesis was not disturbed (Fig. 3C, a-d) . By E9.5, the large vitelline collecting vessels and the small capillary branching vessels were well differentiated and filled with erythrocyte in the wild-type yolk sacs (Fig. 3C, e and g ). In contrast, in RA-GEF-rl-yolk sacs, the blood islands were occasionally dilated, and the endodermal layer exhibited a characteristic buckling appearance, which could be due to disruption of endothelial cell adhesion as observed in mice deficient in transforming growth factor-J31 [18] (Fig. 3C, f and h ). Moreover, they contained smaller number of erythrocytes, which was consistent with the pale appearance of RA-GEF-r l -yolk sacs (Fig. 2C) . These results suggest that RA-GEF-l plays a crucial role in the late stage of vasculogenesis (formation of a primitive vascular plexus), but not in the earlier step (formation of blood islands) in yolk sacs.
Defective vascular development in RA-GEF-rl-placentas
Histological analysis of placentas from RA-GEF-rl-conceptuses also showed abnormal vascular development. In normal development, after the attachment of allantois to chorion, the allantoic vessels undergo further angiogenesis to invade the chorionic plate by E8.5 and form a labyrinthine layer, where embryonic blood vessels are intertwined with maternal lacunae by E9.5 [19] . At E9.5, the labyrinthine layer of wild-type placentas possesses dense networks of embryonic vessels containing nucleated erythrocytes (Fig. 3D) . In contrast, the labyrinthine layer of RA-GEF-r l -placentas was markedly reduced in thickness and much less vascularized with embryonic vessels (Fig. 3D) . Embryonic vessels of RA-GEF-rlplacentas also contained smaller number of erythrocytes.
Discussion
During embryogenesis, the vascular system is formed by two main processes, vasculogenesis and angiogenesis. In vasculogenesis, the endothelial cells differentiate from endothelial progenitor cells and coalesce into a primary vascular plexus. During angiogenesis, the primitive vasculature is remodeled to form the more complex vasculature [17, 20] . We demonstrate that blood island formation and hematopoiesis are not affected until ES.5, but blood islands fail to fuse with each other to form a primary vascular plexus by E9.5 in RA-GEF-r l -yolk sacs, which is compatible with the temporal pattern of RA-GEF-l expression that starts around ES.5. Given almost no RA-GEF-rl-embryos survive beyond E9.5, the failure in yolk sac vasculature may be the primary cause of their mid-gestation death because the yolk sac serves nutritive and metabolic functions to ensure normal development of the embryo before the functional placenta is formed around ElO.5.
One notable feature of the RA-GEF-r l -embryos proper is considerable difference in the severity of the vascular phenotypes observed at E9.5. Only the local primitive vascular networks are observed in severely affected RA-GEF-rl-embryos, however, the hypomorphic dorsal aortae and intersomitic vessels are visible in less affected ones (Fig. 3A) . This high extent of variability could be due to asynchrony of development, which may arise from the mixed genetic background of the mice (129/01a x C57BL/6). Alternatively, the defective vascular development in RA-GEF-r l -embryos proper may be secondary to the embryonic death caused by the overall failure of the yolk sac vasculature. Likewise, the observed abnormalities in RA-GEF-rl-embryos, such as growth retardation, defective neural tube closure and incomplete embryonic turning, may also reflect the failure of the yolk sac vasculature.
Interestingly, 3 out of 12 E9.5 RA-GEF-r l -embryos had a large, swollen allantois which is not connected to the chorion. Similar abnormal development of the allantois is observed in mouse embryos lacking (x'4 integrin [15] or its counter receptor, VCAM-l [16] . (x'4 integrin and VCAM-l are normally expressed in a reciprocal pattern in the chorion and allantois, and the interaction of the two counter receptors is required for formation of the chorioallantois.
Thus, RA-GEF-l might regulate Rapl that is involved in (x'4 integrin-VCAM-l-dependent chorioallantoic fusion. The vascular defects in RA-GEF-r l -embryos are also manifested in the placentas. However, it is presently unclear whether the phenotypes are due to impaired S angiogenic sprouting or simply a consequence of defective blood vessel formation at these sites.
In this paper, we have demonstrated that RA-GEF-l plays a crucial role in embryonic vascular development. To our knowledge, this is the first demonstration of deficient vasculogenesis in mice lacking Rap 1 signaling molecules. However, mechanisms underlying RA-GEF-l-dependent vasculogenesis remain unclear. RA-GEF-l associates with the adaptor protein MAGI-I, which is required for the cell-cell contact-dependent Rapl activation and enhancement of VE-cadherin-mediated cell adhesion [21, 22] . Thus, RA-GEF-IIMAGI-l interaction may have a role in vasculogenesis in mice. It is also noteworthy that orthologs of RA-GEFs, such as PXF-l in Caenorhabditis elegans and Dizzy in Drosophila melanogaster, play an important role to regulate cell-cell and cell-matrix adhesions [23, 24] . Vasculogenesis defects in yolk sacs were also observed in mice lacking fibronectin, a5 integrin, VE-cadherin, or N-cadherin, suggesting that abnormal vasculogenesis observed in RA-GEF-rl-mice may be ascribed to impaired cell adhesion mediated by integrins and cadherins downstream of Rapl [25] [26] [27] [28] . Further studies employing tissue-or cell-type-specific RA-GEF-l knockout mice and cultured vascular endothelial cells will be necessary to elucidate the molecular mechanisms. 
